Correlation Between Eliem Therapeutics and RenovoRx
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and RenovoRx, you can compare the effects of market volatilities on Eliem Therapeutics and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and RenovoRx.
Diversification Opportunities for Eliem Therapeutics and RenovoRx
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eliem and RenovoRx is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and RenovoRx go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and RenovoRx
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the RenovoRx. In addition to that, Eliem Therapeutics is 1.15 times more volatile than RenovoRx. It trades about -0.29 of its total potential returns per unit of risk. RenovoRx is currently generating about 0.37 per unit of volatility. If you would invest 98.00 in RenovoRx on August 29, 2024 and sell it today you would earn a total of 38.00 from holding RenovoRx or generate 38.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 90.91% |
| Values | Daily Returns |
Eliem Therapeutics vs. RenovoRx
Performance |
| Timeline |
| Eliem Therapeutics |
| RenovoRx |
Eliem Therapeutics and RenovoRx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and RenovoRx
The main advantage of trading using opposite Eliem Therapeutics and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| RenovoRx vs. Eliem Therapeutics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals | RenovoRx vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |